Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer [Phase 2]
A Phase 2 trial evaluating radiation therapy and cisplatin with or without cetuximab for stage IB–IIIB cervical cancer has completed.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating TI-0093 injections for HPV-16 positive recurrent or metastatic cancers is currently recruiting. The targ…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya [NA]
A clinical trial update describes a community clinic model aimed at improving early detection of breast and cervical cancers in Kenya; the s…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer [Phase 2]
This Phase 2 clinical trial evaluates neoadjuvant Ivonescimab plus chemotherapy followed by concurrent chemoradiotherapy in high-risk locall…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation [Phase 1, Phase 2]
A clinical trial evaluating whether alendronate can reduce pelvic insufficiency fractures in cervical cancer patients undergoing chemoradiat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for HiFiBiO's HFB200301 as a single agent and in combination with tislelizumab in adults with advanc…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
A completed clinical trial surveying lymphedema after sentinel lymph node biopsy in people with cervical or vulvar cancer.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination [NA]
This clinical trial is evaluating whether sending reminders about HPV vaccination via adolescents' preferred communication methods increases…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) [Phase 3]
Phase 3 clinical trial evaluating a recombinant multivalent HPV vaccine (types 6,11,16,18,31,33,45,52,58) for efficacy, immunogenicity, and …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma
This clinical trial update reports a Chinese cohort study of cervical large cell neuroendocrine carcinoma. The trial status is not yet recru…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
This ongoing clinical trial is evaluating genotyping-based screening and same-day self-sampling as a method to prevent cervical cancer. The …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) [Phase 2]
A Phase 2 trial named TRACTION investigating immunotherapy induction for advanced cervical cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 3]
This document provides a clinical trial update on a Phase 3 study evaluating AK104 in combination with platinum-containing chemotherapy, wit…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer [EARLY_Phase 1]
Early-phase study evaluating the use of PET/MRI for evaluating resectable Stage IA1-IB3 cervical cancer; status is active but not recruiting…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Building Connections [NA]
Massachusetts General Hospital is recruiting for a clinical trial covering colorectal cancer, cervical cancer, depression, anxiety, and obes…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwa…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 [Phase 1, Phase 2]
A phase 1/2 trial evaluating afuresertib in combination with sintilimab and chemotherapy in selected solid tumors resistant to prior PD-1/PD…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer [Phase 2]
A Phase II clinical trial evaluating SHR-A1811 in HER2-expressing recurrent or metastatic cervical cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
This is a screening study by TScan Therapeutics to collect samples for tumor-associated antigens, HLA typing, and HLA loss of heterozygosity…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer [Phase 3]
A Phase 3 trial is evaluating SYS6002 versus standard chemotherapy for recurrent or metastatic cervical cancer, with the study currently not…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
This clinical trial update reports on cervical cancer screening for transgender men in France. The study is currently active but not enrolli…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]
Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, spon…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: mSaada: A Mobile Health Tool [NA]
Duke University is sponsoring a clinical trial to evaluate mSaada, a mobile health tool, for cervical cancer and HPV-related conditions, cur…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries [NA]
Clinical trial evaluating optimization of cervical cancer screening among women living with HIV in Latin America; the study is active but no…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial [NA]
A clinical trial update indicates the Comprehensive Radiobiology Assessment trial examining microenvironment effects of radiotherapy is curr…